443 related articles for article (PubMed ID: 32528402)
1. New Therapies for Advanced Thyroid Cancer.
Laha D; Nilubol N; Boufraqech M
Front Endocrinol (Lausanne); 2020; 11():82. PubMed ID: 32528402
[TBL] [Abstract][Full Text] [Related]
2. Novel targeted therapies and immunotherapy for advanced thyroid cancers.
Naoum GE; Morkos M; Kim B; Arafat W
Mol Cancer; 2018 Feb; 17(1):51. PubMed ID: 29455653
[TBL] [Abstract][Full Text] [Related]
3. New Horizons: Emerging Therapies and Targets in Thyroid Cancer.
Ringel MD
J Clin Endocrinol Metab; 2021 Jan; 106(1):e382-e388. PubMed ID: 32977343
[TBL] [Abstract][Full Text] [Related]
4. Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations.
Smith N; Nucera C
J Clin Endocrinol Metab; 2015 Jan; 100(1):35-42. PubMed ID: 25347569
[TBL] [Abstract][Full Text] [Related]
5. PI3K/Akt/mTOR: A promising therapeutic target for non-medullary thyroid carcinoma.
Petrulea MS; Plantinga TS; Smit JW; Georgescu CE; Netea-Maier RT
Cancer Treat Rev; 2015 Sep; 41(8):707-13. PubMed ID: 26138515
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation alterations as therapeutic prospects in thyroid cancer.
Zhang K; Li C; Liu J; Tang X; Li Z
J Endocrinol Invest; 2019 Apr; 42(4):363-370. PubMed ID: 29992502
[TBL] [Abstract][Full Text] [Related]
7. Evolving molecularly targeted therapies for advanced-stage thyroid cancers.
Bible KC; Ryder M
Nat Rev Clin Oncol; 2016 Jul; 13(7):403-16. PubMed ID: 26925962
[TBL] [Abstract][Full Text] [Related]
8. Targeting vascular endothelial growth factor (VEGF) pathway in iodine-refractory differentiated thyroid carcinoma (DTC): from bench to bedside.
Abdel-Rahman O
Crit Rev Oncol Hematol; 2015 Apr; 94(1):45-54. PubMed ID: 25560732
[TBL] [Abstract][Full Text] [Related]
9. Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy.
Chen H; Luthra R; Routbort MJ; Patel KP; Cabanillas ME; Broaddus RR; Williams MD
Mol Cancer Ther; 2018 Jul; 17(7):1575-1584. PubMed ID: 29695638
[TBL] [Abstract][Full Text] [Related]
10. Current Concepts in the Molecular Genetics and Management of Thyroid Cancer: An Update for Radiologists.
Kelil T; Keraliya AR; Howard SA; Krajewski KM; Braschi-Amirfarzan M; Hornick JL; Ramaiya NH; Tirumani SH
Radiographics; 2016; 36(5):1478-93. PubMed ID: 27618325
[TBL] [Abstract][Full Text] [Related]
11. Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer.
Fullmer T; Cabanillas ME; Zafereo M
Front Endocrinol (Lausanne); 2021; 12():720723. PubMed ID: 34335481
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapy: a new hope for thyroid carcinomas.
Perri F; Pezzullo L; Chiofalo MG; Lastoria S; Di Gennaro F; Scarpati GD; Caponigro F
Crit Rev Oncol Hematol; 2015 Apr; 94(1):55-63. PubMed ID: 25465739
[TBL] [Abstract][Full Text] [Related]
13. BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review).
Leonardi GC; Candido S; Carbone M; Raiti F; Colaianni V; Garozzo S; CinĂ D; McCubrey JA; Libra M
Mol Med Rep; 2012 Oct; 6(4):687-94. PubMed ID: 22858857
[TBL] [Abstract][Full Text] [Related]
14. [Genetic alterations in MAPK and PI3K/Akt signaling pathways and the generation, progression, diagnosis and therapy of thyroid cancer].
Liu B; Kuang A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Dec; 29(6):1221-5. PubMed ID: 23469561
[TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives.
Ceolin L; Duval MADS; Benini AF; Ferreira CV; Maia AL
Endocr Relat Cancer; 2019 Aug; 26(9):R499-R518. PubMed ID: 31252403
[TBL] [Abstract][Full Text] [Related]
16. Molecular-Driven Therapy in Advanced Thyroid Cancer.
Miller KC; Chintakuntlawar AV
Curr Treat Options Oncol; 2021 Feb; 22(3):24. PubMed ID: 33569661
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapy in thyroid cancer.
Nixon IJ; Shaha AR; Tuttle MR
Curr Opin Otolaryngol Head Neck Surg; 2013 Apr; 21(2):130-4. PubMed ID: 23435040
[TBL] [Abstract][Full Text] [Related]
18. Lenvatinib: Role in thyroid cancer and other solid tumors.
Cabanillas ME; Habra MA
Cancer Treat Rev; 2016 Jan; 42():47-55. PubMed ID: 26678514
[TBL] [Abstract][Full Text] [Related]
19. Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy.
Liu J; Liu Y; Lin Y; Liang J
Endocrinol Metab (Seoul); 2019 Sep; 34(3):215-225. PubMed ID: 31565873
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Differentiated Thyroid Carcinomas.
Lechner MG; Praw SS; Angell TE
Surg Pathol Clin; 2019 Dec; 12(4):931-942. PubMed ID: 31672299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]